Neonatal peritoneal candidiasis successfully treated with anidulafungin add-on therapy

Annals of Pharmacotherapy

Volumn 43, Issue 11, 2009, Pages 1907-1910

  Varisco, Brian Michael ^a   Benner, Kimberley W ^b   Prabhakaran, Priya ^a  

^a UNIVERSITY OF ALABAMA AT BIRMINGHAM   (United States)

^b SAMFORD UNIVERSITY   (United States)

Author keywords

Amphotericin B; Anidulafungin; Echinocandins; Intestinal perforation; Neonate; Peritonitis

Indexed keywords

ALANINE AMINOTRANSFERASE; AMPHOTERICIN B LIPID COMPLEX; ANIDULAFUNGIN; ASPARTATE AMINOTRANSFERASE; BILIRUBIN; CREATININE; FLUCONAZOLE; NITRIC OXIDE; PIPERACILLIN PLUS TAZOBACTAM; VANCOMYCIN;

ABDOMINAL COMPARTMENT SYNDROME; ADD ON THERAPY; ADULT RESPIRATORY DISTRESS SYNDROME; ANTIFUNGAL SUSCEPTIBILITY; APPENDECTOMY; ARTICLE; ARTIFICIAL VENTILATION; CANDIDA ALBICANS; CANDIDIASIS; CASE REPORT; COLITIS; COLON RESECTION; CREATININE BLOOD LEVEL; DIARRHEA; EGGERTHELLA LENTA; ENTEROBACTER CLOACAE; FEMALE; FOLLOW UP; FUNGUS GROWTH; HIRSCHSPRUNG DISEASE; HOSPITAL DISCHARGE; HOSPITALIZATION; HUMAN; ILEOSTOMY; INFANT; INTESTINE PERFORATION; KIDNEY DYSFUNCTION; LACTIC ACIDOSIS; LAPAROTOMY; MICROSCOPY; MULTIPLE ORGAN FAILURE; NONHUMAN; PARENTERAL NUTRITION; PERITONEAL CANDIDIASIS; POSTOPERATIVE PERIOD; PRIORITY JOURNAL; PULMONARY HYPERTENSION; RENAL REPLACEMENT THERAPY; RESPIRATORY FAILURE; RESUSCITATION; SEPSIS; SEPTIC SHOCK; SMALL INTESTINE PERFORATION; URINE CULTURE; WOUND DRAINAGE;

AMPHOTERICIN B; CANDIDIASIS; DRUG THERAPY, COMBINATION; ECHINOCANDINS; FEMALE; HUMANS; INFANT, NEWBORN; PERITONEAL CAVITY; TREATMENT OUTCOME;

EID: 70449700242     PISSN: 10600280     EISSN: None     Source Type: Journal    
DOI: 10.1345/aph.1M350     Document Type: Article

References (23)

1. Mollitt DL, Tepas JJ 3rd, Talbert JL. The microbiology of neonatal peritonitis. Arch Surg 1988;123:176-179
2. Coates EW, Karlowicz MG, Croitoru DP, Buescher ES. Distinctive distribution of pathogens associated with peritonitis in neonates with focal intestinal perforation compared with necrotizing enterocolitis. Pediatrics 2005;116:e241-6.
3. Montravers P, Dupont H, Gauzit R, et al. Candida as a risk factor for mortality in peritonitis. Crit Care Med 2006;34:646-652 DOI 10.1097/01.CCM. 0000201889.39443.D2
4. Blot SI, Vandewoude KH, De Waele JJ. Candida peritonitis. Curr Opin Crit Care 2007;13:195-199
5. Kaufman D, Fairchild KD. Clinical microbiology of bacterial and fungal sepsis in very-low-birth-weight infants. Clin Microbiol Rev 2004;17: 638-680 DOI 10.1128/CMR.17.3.638-680.2004 (Pubitemid 38970686)
6. Manzoni P, Leonessa M, Galletto P, et al. Routine use of fluconazole prophylaxis in a neonatal intensive care unit does not select natively fluconazole- resistant Candida subspecies. Pediatr Infect Dis J 2008;27:731-737 DOI 10.1097/MCC.0b013e328028fd92
7. Healy CM, Campbell JR, Zaccaria E, Baker CJ. Fluconazole prophylaxis in extremely low birth weight neonates reduces invasive candidiasis mortality rates without emergence of fluconazole-resistant Candida species. Pediatrics 2008;121:703-710 DOI 10.1542/peds.2007-1130
8. Pfaller MA, Diekema DJ. Epidemiology of invasive candidiasis: a persistent public health problem. Clin Microbiol Rev 2007;20:133-163 DOI 10.1128/CMR.00029-06
9. Vazquez JA. Anidulafungin: a new echinocandin with a novel profile. Clin Ther 2005;27:657-673 DOI 10.1016/j.clinthera.2005.06.010
10. Pappas PG, Kauffman CA, Andes D, et al. Clinical practice guidelines for the management of candidiasis: 2009 update by the Infectious Diseases Society of America. Clin Infect Dis 2009;48:503-535 DOI 10.1086/596757
11. Reboli AC, Rotstein C, Pappas PG, et al. Anidulafungin versus fluconazole for invasive candidiasis. N Engl J Med 2007;356:2472-2482 DOI 10.1056/NEJMoa066906 (Pubitemid 46919773)
12. Product information. Cancidas (caspofungin). Whitehouse Station, NJ: Merck, July 2008.
13. Product information. Mycamine (micafungin). Deerfield, IL: Astellas Pharma, January 2008.
14. Product information. Eraxis (anidulafungin). New York: Pfizer, May 2007.
15. Queiroz-Telles F, Berezin E, Leverger G, et al. Micafungin versus liposomal amphotericin B for pediatric patients with invasive candidiasis: substudy of a randomized double-blind trial. Pediatr Infect Dis J 2008;27: 820-826 DOI 10.1097/INF.0b013e31817275e6
16. Benjamin DK Jr, Driscoll T, Seibel NL, et al. Safety and pharmacokinetics of intravenous anidulafungin in children with neutropenia at high risk for invasive fungal infections. Antimicrob Agents Chemother 2006;50: 632-638 DOI 10.1128/AAC.50.2.632-638.2006 (Pubitemid 43190976)
17. Blowey DL, Garg UC, Kearns GL, Warady BA. Peritoneal penetration of amphotericin B lipid complex and fluconazole in a pediatric patient with fungal peritonitis. Adv Perit Dial 1998;14:247-250
18. Frattarelli DA, Reed MD, Giacoia GP, Aranda JV. Antifungals in systemic neonatal candidiasis. Drugs 2004;64:949-968 DOI 10.2165/00003495-200464090-00003
19. Johnson DE, Conroy MM, Foker JE, Ferrieri P, Thompson TR. Candida peritonitis in the newborn infants. J Pediatr 1980;97:298-300.
20. Bond S, Stewart DL, Bendon RW. Invasive Candida enteritis of the newborn. J Pediatr Surg 2000;35:1496-1498 DOI 10.1053/jpsu.2000.16423
21. Freydiere AM, Piens MA, Andre JM, Putet G, Picot S. Successful treatment of Candida glabrata peritonitis with fluconazole plus flucytosine in a premature infant following in vitro fertilization. Eur J Clin Microbiol Infect Dis 2005;24:704-705 DOI 10.1007/s10096-005-0034-6
22. Kaplan M, Eidelman AI, Dollberg L, Abu-Dalu K. Necrotizing bowel disease with Candida peritonitis following severe neonatal hypothermia. Acta Paediatr Scand 1990;79:876-879 DOI 10.1111/j.1651-2227.1990.tb11574.x
23. Mintz AC, Applebaum H. Focal gastrointestinal perforations not associated with necrotizing enterocolitis in very low birth weight neonates. J Pediatr Surg 1993;28:857-860 DOI 10.1016/0022-3468(93)90345-L (Pubitemid 23176051)